million people affected worldwide
Current Treatments
Psychedelic research currently is in Preclinical
Psychedelics are developing as medicines at the same time when digital therapeutics are entering regular practice. Where they intersect is what this page will be about.
This topic is currently a stub, it will be expanded upon in the near future.
Highlighted Institutes
These are the institutes, from companies to universities, who are working on Technology.
Terran Biosciences
Terran Biosciences is developing a portfolio of drugs, an imaging device, and a precision medicine platform to treat a variety of neurological and psychiatric illnesses.
Eve Health Systems
Eve Health Systems is a data-driven health platform with a focus on the emerging psychedelic-assisted therapies market.
Highlighted People
These are some of the best-known people, from researchers to entrepreneurs, working on Technology.
Linked Research Papers about Technology
Language Models Learn Sentiment and Substance from 11,000 Psychoactive Experiences
Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics
Psychedelics and virtual reality: parallels and applications
Employing Synergistic Interactions of Virtual Reality and Psychedelics in Neuropsychopharmacology
Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics
Virtual Reality and Psychedelics for the Treatment of Psychiatric Disease: A Systematic Literature Review
Psychedelic Resting-state Neuroimaging: A Review and Perspective on Balancing Replication and Novel Analyses
Application of machine learning and complex network measures to an EEG dataset from ayahuasca experiments
Neuroimaging in psychedelic drug development: Past, present, and future
Increased Entropic Brain Dynamics during DeepDream-Induced Altered Perceptual Phenomenology
Structure-based discovery of nonhallucinogenic psychedelic analogs
Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy